Welcome to LookChem.com Sign In|Join Free
  • or
2-(2-(benzyloxy)-5-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

779331-12-3

Post Buying Request

779331-12-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

779331-12-3 Usage

Chemical class

boronic acids

Common use

reagent in organic synthesis, specifically in the Suzuki-Miyaura cross-coupling reaction for carbon-carbon bond formation

Structure

contains a boron atom bonded to two oxygen atoms and an aryl group

Functionalities

unique combination of aromatic and boronic functionalities, valuable for pharmaceuticals, agrochemicals, and materials science development

Trifluoromethyl group

enhances lipophilicity and can influence biological activity and pharmacokinetic properties.

Check Digit Verification of cas no

The CAS Registry Mumber 779331-12-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,9,3,3 and 1 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 779331-12:
(8*7)+(7*7)+(6*9)+(5*3)+(4*3)+(3*1)+(2*1)+(1*2)=193
193 % 10 = 3
So 779331-12-3 is a valid CAS Registry Number.

779331-12-3Relevant academic research and scientific papers

SULFONAMIDE COMPOUNDS AS VOLTAGE GATED SODIUM CHANNEL MODULATORS

-

Page/Page column 88, (2015/12/09)

The present invention relates to the compound of Formula (I) wherein the substituents are as described herein, and their use in a medicine for the treatment of diseases, disorders associated with the inhibition of Voltage-gated sodium channels (VGSC) particularly NaV1.7. It further relates to the compounds herein and their pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof useful in treating diseases, disorders, syndromes and/or conditions associated with the inhibition of Voltage-gated sodium channels (VGSC) particularly NaV1.7. The invention also relates to process for the preparation of the compounds of the invention.

NOVEL COMPOUNDS

-

Page/Page column 38-39, (2010/10/20)

Novel Compounds The invention relates to substituted acids as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.

NOVEL COMPOUNDS

-

Page 95, (2010/02/09)

The invention relates to substituted phenoxyacetic acids (I) as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 779331-12-3